RESEARCH. The University of Gothenburg and Region Västra Götaland are establishing a joint infrastructure for sample and tissue management and collection of quality registry data for cancer patients in the region. The initiative was made possible through a grant from the Sjöberg Foundation, and will create better opportunities for personalized cancer treatments. Future cancer treatments will become increasingly more customized according to each individual’s characteristics. In all cancers, there are genetic…
Advanced Animal Modeling Reveals New Ways of Treating Malignant Melanoma
RESEARCH MODEL. Currently available treatments for malignant melanoma can cure certain patients – but not all. A group of researchers from the Sahlgrenska Cancer Center at the University of Gothenburg have demonstrated that an advanced new animal model known as “avatar mice” can be used in research to understand why treatment is not always successful, and by extension improve the prognosis for this form of skin cancer. Their findings are…
Fatal glandular cancer will soon be possible to treat
NEW STUDY. A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon. Adenoid cystic carcinoma is a slow-growing but fatal form of cancer originating from different glandular tissues in for example the head and neck, the breast, the…
Flexible new method for early cancer diagnosis
RESEARCH. Earlier discovery of cancer and greater precision in the treatment process are the objectives of a new method developed by researchers at Sahlgrenska Academy and Boston University. Investments are now being made to roll out this innovation across healthcare and broaden the scope of the research in this field. “We can screen at-risk patient groups, and we also plan to spot the cancer patients who are relapsing so that…
Taking sabbatical in the US with support from SSF
CONTRIBUTION. Sukanya Raghavan, Associate Professor at the Department of Microbiology and Immunology, will shortly take a sabbatical from the Sahlgrenska Academy, to work at Merck Research Laboratories in Palo Alto, California. Her position as guest researcher in the US is funded by contributions from SSF’s call in the strategic mobility. What does the mobility grant mean for your research and for you? The Mobility grant from SSF gives me the…